scholarly article | Q13442814 |
P2093 | author name string | D. E. Richmond | |
P2860 | cites work | Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide | Q33567800 |
The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis | Q40912817 | ||
The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus | Q41012277 | ||
Patterns of nuclear fluorescence and DNA-binding activity | Q41314196 | ||
The prognosis of lupus nephritis. Role of clinical-pathologic correlations | Q41940079 | ||
Efficacy of immunosuppressive drugs in rheumatic diseases | Q43840658 | ||
Experimental characterization of the immunosuppressive properties of thiamphenicol | Q44430275 | ||
The dosage regimen of thiamphenicol in patients with kidney disease | Q68922515 | ||
Chloramphenicol-thiamphenicol induced lymphocyte blastogenesis depression | Q68922532 | ||
A comparison of the immunosuppressive effects of thiamphenicol and cyclophosphamide in the rat renal transplant model | Q69369996 | ||
Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis | Q69498786 | ||
Renal histologic findings in systemic lupus erythematosus | Q72531277 | ||
AUTO-ANTIBODIES TO CELL NUCLEI | Q76528782 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | internal medicine | Q11180 |
immunosuppression | Q1455316 | ||
P304 | page(s) | 670-675 | |
P577 | publication date | 1979-12-01 | |
P1433 | published in | Australian and New Zealand journal of medicine | Q27709236 |
P1476 | title | Thiamphenicol as an Immunosuppressant in Active Systemic Lupus Erythematosus with Nephritis | |
P478 | volume | 9 |
Search more.